$1.20
-0.01-0.83%
al cierre: -
$1.15
-0.05-4.17%
After hour: Nov 14, 7:59 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Salarius Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
ago 12
BPA
$-6.750
Ingresos trimestrales
$0.00
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
–
Analice el historial de beneficios de Salarius Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
SLRX | Salarius Pharmaceuticals | -$11.40 | — | — | — | $0.00 | — | — | — | 11/28/2025 | |
SLRX | Salarius Pharmaceuticals | -$35.55 | — | -$6.75 | — | $0.00 | — | $0.00 | — | 08/12/2025 | |
SLRX | Salarius Pharmaceuticals | -$49.20 | — | -$15.45 | — | $0.00 | — | $0.00 | — | 05/14/2025 | |
SLRX | Salarius Pharmaceuticals | -$26.40 | — | -$9.90 | — | $0.00 | — | $0.00 | — | 03/24/2025 | |
SLRX | Salarius Pharmaceuticals | -$78.00 | -$36.00 | -$11.40 | 68.33% | $0.00 | — | $0.00 | — | 11/14/2024 | |
SLRX | Salarius Pharmaceuticals | -$171.60 | -$804.00 | -$35.55 | 95.58% | $0.00 | — | $0.00 | — | 08/09/2024 | |
SLRX | Salarius Pharmaceuticals | -$267.60 | -$804.00 | -$49.20 | 93.88% | $0.00 | — | $0.00 | — | 05/13/2024 | |
SLRX | Salarius Pharmaceuticals | -$339.60 | -$121.20 | -$26.40 | 78.22% | $0.00 | — | $0.00 | — | 03/22/2024 | |
SLRX | Salarius Pharmaceuticals | -$296.40 | -$144.00 | -$78.00 | 45.83% | $0.00 | — | $0.00 | — | 11/09/2023 | |
SLRX | Salarius Pharmaceuticals | -$270.00 | -$156.00 | -$171.60 | -10.00% | $0.00 | — | $0.00 | — | 08/10/2023 | |
SLRX | Salarius Pharmaceuticals | -$396.00 | -$310.80 | -$267.60 | 13.90% | $0.00 | — | $0.00 | — | 05/11/2023 | |
SLRX | Salarius Pharmaceuticals | -$272.40 | -$258.00 | -$339.60 | -31.63% | $0.00 | — | $0.00 | — | 03/27/2023 | |
SLRX | Salarius Pharmaceuticals | -$250.80 | -$306.00 | -$296.40 | 3.14% | $0.00 | — | $0.00 | — | 11/10/2022 | |
SLRX | Salarius Pharmaceuticals | -$210.00 | -$300.00 | -$270.00 | 10.00% | $571.39K | — | $0.00 | — | 08/05/2022 | |
SLRX | Salarius Pharmaceuticals | -$180.00 | -$270.00 | -$390.00 | -44.44% | $1.27M | — | $0.00 | — | 05/12/2022 | |
SLRX | Salarius Pharmaceuticals | -$300.00 | -$240.00 | -$270.00 | -12.50% | $1.48M | $430.00K | $0.00 | -100.00% | 03/10/2022 | |
SLRX | Salarius Pharmaceuticals | -$300.00 | -$180.00 | -$240.00 | -33.33% | $1.38M | $1.16M | $0.00 | -100.00% | 11/04/2021 | |
SLRX | Salarius Pharmaceuticals | -$390.00 | -$180.00 | -$210.00 | -16.67% | $1.24M | $1.28M | $571.39K | -55.36% | 08/05/2021 | |
SLRX | Salarius Pharmaceuticals | -$660.00 | -$150.00 | -$180.00 | -20.00% | $1.13M | $1.37M | $1.27M | -7.37% | 05/12/2021 | |
SLRX | Salarius Pharmaceuticals | -$1.32K | -$330.00 | -$300.00 | 9.09% | $1.04M | $1.48M | $1.48M | -0.07% | 03/18/2021 |
Salarius Pharmaceuticals (SLRX) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-11.40 | $-36.00 | 68.3 % |
| Q2 | 2024-08-09 | $-35.55 | $-804.00 | 95.6 % |
| Q1 | 2024-05-13 | $-49.20 | $-804.00 | 93.9 % |
| Q4 | 2024-03-22 | $-26.40 | $-121.20 | 78.2 % |
Salarius Pharmaceuticals (SLRX) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q4 | 2022-03-10 | $0 | $430.00K | -100.0 % |
| Q3 | 2021-11-04 | $0 | $1.16M | -100.0 % |
| Q2 | 2021-08-05 | $571.39K | $1.28M | -55.4 % |
| Q1 | 2021-05-12 | $1.27M | $1.37M | -7.37 % |
PREGUNTAS FRECUENTES
¿Cuándo Salarius Pharmaceuticals (NASDAQ:SLRX) publicará los resultados?
Está previsto que Salarius Pharmaceuticals (SLRX) presente resultados el noviembre 28, 2025. Los últimos resultados se publicaron el agosto 12, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Salarius Pharmaceuticals (NASDAQ:SLRX)?
El BPA real fue de $-6.75, que no alcanzó la estimación de $0.00.
¿Cuáles fueron los ingresos de Salarius Pharmaceuticals (NASDAQ:SLRX)?
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.